Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 30, 2023 16:08 ET | Source: Miromatrix Medical Inc.

Miromatrix Presenting at the 2023 American Transplant Congress

EDEN PRAIRIE, Minn., May 30, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
May 30, 2023 16:05 ET | Source: Miromatrix Medical Inc.

Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference

EDEN PRAIRIE, Minn., May 30, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
May 11, 2023 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update

EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
April 27, 2023 18:00 ET | Source: Miromatrix Medical Inc.

Miromatrix to Report First Quarter 2023 Financial Results

EDEN PRAIRIE, Minn., April 27, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
April 10, 2023 07:01 ET | Source: Miromatrix Medical Inc.

Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med

EDEN PRAIRIE, Minn., April 10, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
April 05, 2023 06:50 ET | Source: Miromatrix Medical Inc.

CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation

CareDx Exclusive Provider of dd-cfDNA Testing Services for Use in Miromatrix Clinical Trials Companies at Forefront of Alternative Organ Supply Research to Address Organ Shortage BRISBANE,...
March 31, 2023 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix Reports Fourth Quarter and Full Year 2022 Results and Provides Corporate Update

EDEN PRAIRIE, Minn., March 31, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
March 15, 2023 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix to Report Fourth Quarter and Full Year 2022 Financial Results

EDEN PRAIRIE, Minn., March 15, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
March 07, 2023 20:35 ET | Source: Miromatrix Medical Inc.

Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock

EDEN PRAIRIE, Minn., March 07, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO), a life sciences company pioneering a novel technology for bioengineering fully...
March 07, 2023 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock

EDEN PRAIRIE, Minn., March 07, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO), a life sciences company pioneering a novel technology for bioengineering fully...